The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients

International Journal of Clinical Practice

Volumn 65, Issue SUPPL. 172, 2011, Pages 6-14

  Hsu, Chih Hsin ^a,b,c   Gomberg Maitland, M ^b   Glassner, C ^b   Chen, J H ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DEXMEDETOMIDINE; DIURETIC AGENT; DOBUTAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; ETACRYNIC ACID; FENTANYL; FUROSEMIDE; GESTAGEN; HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; MEDROXYPROGESTERONE ACETATE; MIDAZOLAM; NITRIC OXIDE; OXYGEN; PROPOFOL; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SPIRONOLACTONE; TORASEMIDE; VASOPRESSIN; WARFARIN; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ANTICOAGULATION; ARTICLE; BIRTH CONTROL; BLEEDING; CESAREAN SECTION; CONDOM; DRUG DOSE INCREASE; EISENMENGER COMPLEX; EPIDURAL ANESTHESIA; ERYTHROCYTE; FETUS OUTCOME; FORCEPS DELIVERY; GENERAL ANESTHESIA; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART RHYTHM; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFESTYLE MODIFICATION; LUNG ARTERY PRESSURE; LUNG BLOOD VOLUME; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MATERNAL MORTALITY; NONHUMAN; ORAL CONTRACEPTION; OTOTOXICITY; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN THERAPY; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SODIUM RESTRICTION; SYMPTOMATOLOGY; TERATOGENICITY; THROMBOSIS; UTERINE TUBE LIGATION; VAGINAL DELIVERY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HOSPITALIZATION; MORTALITY; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; STANDARD; SURVIVAL RATE; THERAPEUTIC ABORTION;

ABORTION, THERAPEUTIC; EPOPROSTENOL; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PULMONARY; PIPERAZINES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PURINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFONES; SURVIVAL RATE;

EID: 79960109331     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02711.x     Document Type: Article

References (80)

1. D'Alonzo GE, Barst RJ, Ayres SM, et al., Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.
2. Galie N, Hoeper MM, Humbert M, et al., Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-537.
3. Hatano S, Strasser T,. Primary pulmonary hypertension. World Health Organization Geneva: WHO, 1975.
4. Weiss BM, Zemp L, Seifert B, Hess OM,. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650-7. (Pubitemid 28273311)
5. Elkayam U, Gleicher N,. Hemodynamics and cardiac function during normal pregnancy and the puerperium. In:, Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy: Diagnosis and Management of Maternal and Fetal Disease. 3rd edn. New York: Wiley-Liss Inc, 1988. 3-19.
6. Bedard E, Dimopoulos K, Gatzoulis MA,. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009; 30: 256-65.
7. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV,. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-28. (Pubitemid 46981654)
8. McLaughlin VV, Archer SL, Badesch DB, et al., ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-619.
9. Elkayam U, Dave R, Bokhari SWH,. Primary pulmonary hypertension and pregnancy. In:, Elkayam U, Gleicher N, eds. Cardiac problems in Pregnancy: diagnosis and management of maternal and fetal disease. 3rd edn. New York: Wiley-Liss Inc, 1998. 183-10.
10. Hunter S, Robson SC,. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68: 540-3. (Pubitemid 23001727)
11. Ueland K,. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 1976; 126: 671-7.
12. Pritchard JA,. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965; 26: 393-9.
13. Lund CJ, Donovan JC,. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967; 98: 394-403.
14. Robson SC, Hunter S, Boys RJ, Dunlop W,. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256: H1060-5.
15. Capeless EL, Clapp JF,. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 1989; 161: 1449-53. (Pubitemid 20024008)
16. Duvekot JJ, Peeters LL,. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv 1994; 49: 830-9. (Pubitemid 24373639)
17. Ueland K, Hansen JM,. Maternal cardiovascular dynamics. 3. Labor and delivery under local and caudal analgesia. Am J Obstet Gynecol 1969; 103: 8-18.
18. Katz R, Karliner JS, Resnik R,. Effect of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978; 58: 434-41. (Pubitemid 9006970)
19. Atkins AF, Watt JM, Milan P, Davies P, Crawford JS,. A longitudinal study of cardiovascular dynamic changes throught pregnancy. Eur Obstet Gynecol Reprod Biol 1981; 12: 215-24. (Pubitemid 11022340)
20. Clapp JF CE III,. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997; 80: 1469-73.
21. Warnes CA,. Pregnancy and pulmonary hypertension. Int J Cardiol 2004; 97: 11-3. (Pubitemid 39601746)
22. Metcalfe J, Ueland K,. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 1974; 16: 363-74.
23. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA,. Pregnancy and congenital heart disease. BMJ 2006; 332: 401-6. (Pubitemid 43797384)
24. Weiss BM, Hess OM,. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 2000; 21: 104-15. (Pubitemid 30072625)
25. Goland S, Tsai F, Habib M, Janmohamed M, Goodwin TM, Elkayam U,. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension. Cardiology 2010; 115: 205-8.
26. Pechet LAB,. Clotting factors in pregnancy. N Engl J Med 1961; 265: 1093-7.
27. Hellgren M, Blomback M,. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium.I Normal conditions. Gynecol Obstet Invest 1981; 2: 141-54. (Pubitemid 11150978)
28. Madden BP,. Pulmonary hypertension and pregnancy. Int J Obstet Anesth. 2009; 18: 156-64.
29. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M,. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007; 30: 1103-10. (Pubitemid 351194756)
30. Humbert M, Sitbon O, Chaouat A, et al., Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.
31. Daliento L, Somerville J, Presbitero P, et al., Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-55. (Pubitemid 28556655)
32. Jaigobin CSF,. Stroke and pregnancy. Stroke 2003; 31: 2948-51.
33. Gleicher N, Midwall J, Hochberger D, Jaffin H,. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv 1979; 34: 721-41. (Pubitemid 10235313)
34. Thorne S, Nelson-Piercy C, MacGregor A, et al., Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006; 32: 75-81.
35. Vasilakis C, Jick H, del Mar Melero-Montes M,. Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet 1999; 354: 1610-1. (Pubitemid 29515957)
36. Heinemann LA, Assmann A, DoMinh T, Garbe E,. Oral progestogen-only contraceptives and cardiovascular risk: results from the transnational study on oral contraceptives and the health of young women. Eur J Contracept Reprod Health Care 1999; 4: 67-73. (Pubitemid 29318065)
37. Satoh H, Masuda Y, Izuta S, Yaku H, Obara H,. Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy. Anesthesiology 2002; 97: 1638-40. (Pubitemid 35417470)
38. Goto K, Arai M, Watanabe A, Hasegawa A, Nakano A, Kurabayashi M,. Utility of echocardiography versus BNP level for the prediction of pulmonary arterial pressure in patients with pulmonary arterial hypertension. Int Heart J 2010; 51: 343-7.
39. Brierre G, Blot-Souletie N, Degano B, Tetu L, Bongard V, Carrie D,. New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension. Eur J Echocardiogr 2010; 11: 516-22.
40. Wylie BJ, Epps KC, Gaddipati S, Waksmonski CA,. Correlation of transthoracic echocardiography and right heart catheterization in pregnancy. J Perinat Med 2007; 35: 497-502. (Pubitemid 350219127)
41. Al-Mobeireek AF, Almutawa J, Alsatli RA,. The nineteenth pregnancy in a patient with cor pulmonale and severe pulmonary hypertension: a management challenge. Acta Obstet Gynecol Scand 2003; 82: 676-8. (Pubitemid 36735146)
42. Pitts JA, Crosby WM, Basta LL,. Eisenmenger's syndrome in pregnancy: does heparin prophylaxis improve the maternal mortality rate? Am Heart J 1977; 93: 321-6. (Pubitemid 8052438)
43. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: safety of lovenox in pregnancy. Obstet Gynecol 2002; 100: 845-6.
44. Kiely DG, Eillot CA, Webster VJ, et al., Pregnancy and pulmonary hypertension: new approaches to the management of life-threatening condition. In:, Steer PJ, Gatzoulis MA, Baker P, eds. Heart Disease and Pregnancy, 9th edn. London, UK: RCOG Press, 2006: 211-29.
45. Chin KM, Channick RN, Kim NH, Rubin LJ,. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chest 2007; 132: 786-92.
46. Ladakis C, Myrianthefs P, Karabinis A, et al., Central venous and mixed venous oxygen saturation in critically ill patients. Respiration 2001; 68: 279-85. (Pubitemid 32588903)
47. Edwards JD, Mayall RM,. Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. Crit Care Med 1998; 26: 1356-60. (Pubitemid 28384635)
48. Weeks SK, Smith JB,. Obstetric anaesthesia in patients with primary pulmonary hypertension. Can J Anaesth 1991; 38: 814-6.
49. Barash PG, Nardi D, Hammond G, et al., Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg 1981; 82: 5-12. (Pubitemid 11053005)
50. Bonnin M, Mercier FJ, Sitbon O, et al., Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133-7. (Pubitemid 40745831)
51. Cottis R, Magee N, Higgins DJ,. Haemodynamic monitoring with pulse-induced contour cardiac output (PiCCO) in critical care. Intensive Crit Care Nurs 2003; 19: 301-7. (Pubitemid 37221103)
52. Oren-Grinberg A,. The PiCCO Monitor. Int Anesthesiol Clin 2010; 48: 57-85.
53. Kerbaul F, Rondelet B, Demester JP, et al., Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006; 34: 2814-9. (Pubitemid 44610948)
54. Kerbaul F, Rondelet B, Motte S, et al., Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004; 32: 1035-40. (Pubitemid 38471527)
55. Price LC, Forrest P, Sodhi V, et al., Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007; 99: 552-5. (Pubitemid 47412500)
56. Siu SC, Sermer M, Colman JM, et al., Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515-21. (Pubitemid 32738118)
57. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA,. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128: 745-55. (Pubitemid 28204867)
58. Monnery L, Nanson J, Charlton G,. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87: 295-8. (Pubitemid 32750544)
59. Weiss BM, Maggiorini M, Jenni R, et al., Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000; 92: 1191-4. (Pubitemid 30180998)
60. Olofsson C, Bremme K, Forssell G, Ohqvist G,. Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension. Acta Anaesthesiol Scand 2001; 45: 258-60. (Pubitemid 32115699)
61. Wong PS, Constantinides S, Kanellopoulos V, Kennedy CR, Watson D, Shiu MF,. Primary pulmonary hypertension in pregnancy. J R Soc Med 2001; 94: 523-5. (Pubitemid 32959943)
62. Lovell AT,. Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth 2004; 93: 129-39. (Pubitemid 38967435)
63. O'Hare RMC, Milligan K, McNamee D, Sidhu H,. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth 1998; 81: 790-2. (Pubitemid 28499946)
64. Slomka F, Salmeron S, Zetlaoui P, Cohen H, Simonneau G, Samii K,. Primary pulmonary hypertension and pregnancy: anesthetic management for delivery. Anesthesiology 1988; 69: 959-61. (Pubitemid 19021649)
65. Khan MJ, Bhatt SB, Kryc JJ,. Anesthetic considerations for parturients with primary pulmonary hypertension: review of the literature and clinical presentation. Int J Obstet Anesth 1996; 5: 36-42. (Pubitemid 26026776)
66. Toyama H, Wagatsuma T, Ejima Y, Matsubara M, Kurosawa S,. Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine. Int J Obstet Anesth 2009; 18: 262-7.
67. Gogarten W, Vandermeulen E, Van Aken H,. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27: 999-1015.
68. Cousins MJ, Bromage P,. Epidural neural blockade. In:, Cousins MJ, Bromage P, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. Philadephia: JB Lippincott, 1988: 253-360.
69. Fan SZ, Susetio L, Wang YP, Cheng YJ, Liu CC,. Low dose of intrathecal hyperbaric bupivacaine combined with epidural lidocaine for cesarean section - a balance block technique. Anesth Analg 1994; 78: 474-7. (Pubitemid 24079368)
70. Carrie L,. Extradural, spinal or combined block for obstetric surgical anaesthesia. Br J Anaesth 1990; 65: 225-33. (Pubitemid 20244572)
71. Lam GK, Stafford RE, Thorp J, Moise KJ Jr, Cairns BA,. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001; 98: 895-8. (Pubitemid 33042494)
72. Goodwin TM, Gherman RB, Hameed A, Elkayam U,. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol 1999; 180: 64-7. (Pubitemid 29088391)
73. Tacoy G, Ekim NN, Cengel A,. Dramatic response of a patient with pregnancy induced idiopathic pulmonary arterial hypertension to sildenafil treatment. J Obstet Gynaecol Res 2010; 36: 414-7.
74. Easterling TR, Ralph DD, Schmucker BC,. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol 1999; 93: 494-8. (Pubitemid 29147064)
75. Stewart R, Tuazon D, Olson G, Duarte AG,. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest 2001; 119: 973-5. (Pubitemid 32197678)
76. Elliot CA, Stewart P, Webster VJ, et al., The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005; 26: 168-73. (Pubitemid 40945946)
77. Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM,. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 2000; 36: 2204-11.
78. McDonnell NJ, Chan BO, Frengley RW,. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 2007; 16: 269-73. (Pubitemid 46880294)
79. Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J,. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Chest 2004; 125: 580-6. (Pubitemid 38223639)
80. Decoene C, Bourzoufi K, Moreau D, Narducci F, Crepin F, Krivosic-Horber R,. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth 2001; 48: 584-7. (Pubitemid 32684876)